News

The Manila Times
manilatimes.net > 03/17/2026 > tmt-newswire > globenewswire > greenwich-lifesciences-provides-update-showing-continued-reduction-in-recurrence-rate-in-the-open-label-arm-of-flamingo-01 > 2301523

Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01

15+ hour, 2+ min ago  (297+ words) STAFFORD, Texas, March 17, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided a preliminary update…...

The Manila Times
manilatimes.net > 10/15/2025 > tmt-newswire > globenewswire > fieldpoint-private-announces-new-office-in-greenwich-connecticut > 2200775

Fieldpoint Private Announces New Office in Greenwich, Connecticut

5+ mon, 3+ day ago  (139+ words) Convenient ground-level office near Greenwich Avenue at 130 Mason Street to open October 15 GREENWICH, Conn., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fieldpoint Private announced today that it will open a new office at 130 Mason Street, Suite 102, in Greenwich's historic downtown shopping district, on October…...

The Manila Times
manilatimes.net > 09/08/2025 > tmt-newswire > globenewswire > first-disclosure-of-global-interim-phase-2-data-for-biontech-and-bristol-myers-squibb-pd-l1xvegf-a-bispecific-antibody-pumitamig-bnt327bms986545-in-patients-with-extensive-stage-small-cell-lung-cancer-shows-encouraging-antitumor-activity > 2180852

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

6+ mon, 1+ week ago  (119+ words) About the BNT327-01 Phase 2 clinical trial About Small Cell Lung Cancer About pumitamig (also known as BNT327 or BMS986545) About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help…...

The Manila Times
manilatimes.net > 08/27/2025 > tmt-newswire > globenewswire > dutch-miller-nissan-of-bristol-launches-no-addendum-no-markup-policy-redefining-the-car-buying-experience > 2174350

Dutch Miller Nissan of Bristol Launches 'No Addendum, No Markup” Policy, Redefining the Car Buying Experience

6+ mon, 3+ week ago  (259+ words) Bristol, TN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dutch Miller Nissan of Bristol has announced its groundbreaking new approach to retailing: a No Addendum, No Markup policy on all new vehicles. Serving customers from the Tri-Cities, East Tennessee, Virginia, Kentucky, and North Carolina,…...

The Manila Times
manilatimes.net > 06/18/2025 > tmt-newswire > globenewswire > dental-care-of-stamford-announces-breakthrough-bite-based-treatment-during-migraine-awareness-month > 2135259

Dental Care of Stamford announces Breakthrough Bite-Based Treatment During Migraine Awareness Month

9+ mon, 13+ hour ago  (494+ words) STAMFORD, CT, June 17, 2025 (GLOBE NEWSWIRE) -- As Migraine Awareness Month shines a spotlight on one of the most debilitating chronic conditions in the world, Dr. Jerry Simon, a leading dental expert in craniofacial pain and neuromuscular dentistry, is offering a fresh…...

The Manila Times
manilatimes.net > 06/06/2025 > tmt-newswire > globenewswire > american-rebel-ceo-to-perform-at-bristol-dragway-and-american-rebel-light-beer-to-be-featured-at-trackside-bar-and-beer-garden > 2128853

American Rebel CEO to Perform at Bristol Dragway and American Rebel Light Beer to be Featured at Trackside Bar and Beer Garden

9+ mon, 1+ week ago  (338+ words) Super Grip NHRA Thunder Valley Known for his unapologetic, freedom-fueled anthems, Andy Ross will take the stage on Saturday afternoon from 1:45 to 2:45 PM, delivering a powerful, adrenaline-pumping set that celebrates the American spirit, hard work, and unwavering patriotism. His music,…...

The Manila Times
manilatimes.net > 04/02/2025 > tmt-newswire > globenewswire > greenwich-lifesciences-announces-positive-immune-response-data-from-flamingo-01-phase-iii-clinical-trial > 2084966

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

11+ mon, 2+ week ago  (369+ words) These two general immune response findings, immune response at baseline and increasing immune response over time, were also observed in the Phase IIb clinical trial for HLA-A*02 only patients. These ... Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase…...